The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Diagnosis of gastrointestinal stromal tumors: A consensus approach
Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., Remotti, H., Rubin, B. P., et al. (2002) · Human Pathology · doi:10.1053/hupa.2002.123545 · Cited by 3,419
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Self-citationvan der Graaf, W. T., Blay, J.-Y., Chawla, S. P., Kim, D.-W., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,102
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311107 · Cited by 1,495
Demetri, G. D., Reichardt, P., Kang, Y.-K., Blay, J.-Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61857-1 · Cited by 1,406
Self-citationA cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., Schmithorst, V. J., Laor, T., Brody, A. S., Bean, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa063564 · Cited by 1,253
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008) · Cancer · doi:10.1002/cncr.23592 · Cited by 987
Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., Vilain, M. O., Mandard, A. M., Le Doussal, V, Leroux, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.350 · Cited by 864
Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., Milhem, M., Elias, A., Ganjoo, K., Tawbi, H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.4734 · Cited by 841
Self-citationFamilial adenomatous polyposis
Galiatsatos, P., & Foulkes, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00375.x · Cited by 757
Maki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 742
Self-citationFrustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Penel, N., Bui, B. N., Bay, J.-O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., Kerbrat, P., Fournier, C., Taieb, S., Jimenez, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3146 · Cited by 687
Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial
Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., Sabbatini, P., Tong, W., Barakat, R., & Spriggs, D. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.050 · Cited by 683
Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schöffski, P., Collin, F., Pandite, L., Marreaud, S., De Brauwer, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3223 · Cited by 679
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Maki, R. G., D'Adamo, D. R., Keohan, M. L., Saulle, M., Schuetze, S. M., Undevia, S. D., Livingston, M. B., Cooney, M. M., Hensley, M. L., Mita, M. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4495 · Cited by 569
Self-citationDemetri, G. D., Chawla, S. P., von Mehren, M., Ritch, P., Baker, L. H., Blay, J. Y., Hande, K. R., Keohan, M. L., Samuels, B. L., Schuetze, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0088 · Cited by 538
Self-citationLadanyi, M., Antonescu, C. R., Leung, D. H. Y., Woodruff, J. M., Kawai, A., Healey, J. H., Brennan, M. F., Bridge, J. A., Neff, J. R., Barr, F. G., et al. (2002) · PubMed · Cited by 536
Santoro, A., Tursz, T., Mouridsen, H., Verweij, J., Steward, W., Somers, R., Buesa, J., Casali, P., Spooner, D., & Rankin, E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1537 · Cited by 526
Edmonson, J. H., Ryan, L. M., Blum, R. H., Brooks, J. S., Shiraki, M., Frytak, S., & Parkinson, D. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1269 · Cited by 516
Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Antman, K. H., Crowley, J. J., Balcerzak, S. P., Rivkin, S. E., Weiss, G. R., ELIAS, A. D., Natale, R. B., Cooper, R. M., Barlogie, B., & Trump, D. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1276 · Cited by 478
Olivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P. L., & Eeles, R. A. (2003) · PubMed · Cited by 477
Le Cesne, A., Blay, J. Y., Judson, I., Van Oosterom, A., Verweij, J., Radford, J., Lorigan, P., Rodenhuis, S., Ray-Coquard, I., Bonvalot, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.180 · Cited by 421
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues, P., Schäuble, B., Hausen, A. Z., Estève, J., & Ohgaki, H. (1997) · Europe PMC (PubMed Central) · Cited by 411
Wagner, A. J., Malinowska-Kolodziej, I., Morgan, J. A., Qin, W., Fletcher, C. D. M., Vena, N., Ligon, A. H., Antonescu, C. R., Ramaiya, N. H., Demetri, G. D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2981 · Cited by 399
Agulnik, M., Yarber, J. L., Okuno, S. H., von Mehren, M., Jovanovic, B. D., Brockstein, B. E., Evens, A. M., & Benjamin, R. S. (2013) · Annals of Oncology · doi:10.1093/annonc/mds237 · Cited by 389
Self-citationArndt, C. A. S., Stoner, J. A., Hawkins, D. S., Rodeberg, D. A., Hayes-Jordan, A. A., Paidas, C. N., Parham, D. M., Teot, L. A., Wharam, M. D., Breneman, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3768 · Cited by 380
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
Gortzak, E., Azzarelli, A., Buesa, J., Bramwell, V. H. C., van Coevorden, F., van Geel, A. N., Ezzat, A., Santoro, A., Oosterhuis, J. W., van Glabbeke, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00083-1 · Cited by 379
Desmoid tumours in familial adenomatous polyposis.
Gürbüz, A. K., Giardiello, F. M., Petersen, G. M., Krush, A. J., Offerhaus, G. J. A., Booker, S. V., Kerr, M. C., & Hamilton, S. R. (1994) · Gut · doi:10.1136/gut.35.3.377 · Cited by 360
High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004) · Cancer · doi:10.1002/cncr.11937 · Cited by 357
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
Carney, J. A., & Stratakis, C. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10235 · Cited by 350
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
Brems, H., Beert, E., de Ravel, T., & Legius, E. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70033-6 · Cited by 349
Antonescu, C. R., Tschernyavsky, S. J., Decuseara, R., Leung, D. H. Y., Woodruff, J. M., Brennan, M. F., Bridge, J. A., Neff, J. R., Goldblum, J. R., & Ladanyi, M. (2001) · PubMed · Cited by 327
George, S., Merriam, P., Maki, R. G., Van den Abbeele, A. D., Yap, J. T., Akhurst, T., Harmon, D. C., Bhuchar, G., O'Mara, M. M., D'Adamo, D. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9890 · Cited by 321
Self-citationSaylors, R. L., Stine, K. C., Sullivan, J., Kepner, J. L., Wall, D. A., Bernstein, M. L., Harris, M. B., Hayashi, R., & Vietti for the Pediatric Oncology Group, T. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3463 · Cited by 315
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
Yovine, A., Riofrio, M., Blay, J. Y., Brain, E., Alexandre, J., Kahatt, C., Taamma, A., Jimeno, J., Martin, C., Salhi, Y., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.210 · Cited by 310
Davies, D. M., de Vries, P. J., Johnson, S. R., McCartney, D. L., Cox, J. A., Serra, A. L., Watson, P. C., Howe, C. J., Doyle, T., Pointon, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0445 · Cited by 309
García-del-Muro, X., López-Pousa, A., Maurel, J., Martín, J., Martínez-Trufero, J., Casado, A., Gómez-España, A., Fra, J., Cruz, J., Poveda, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6107 · Cited by 307
Kraybill, W. G., Harris, J., Spiro, I. J., Ettinger, D. S., DeLaney, T. F., Blum, R. H., Lucas, D. R., Harmon, D. C., Letson, G. D., & Eisenberg, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5577 · Cited by 278
Davis, A. M., O’Sullivan, B., Bell, R. S., Turcotte, R., Catton, C. N., Wunder, J. S., Chabot, P., Hammond, A., Benk, V., Isler, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.084 · Cited by 278
ELIAS, A. D., RYAN, L. M., Sulkes, A., Collins, J. M., Aisner, J., & Antman, K. H. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1208 · Cited by 275
Cassier, P. A., Gelderblom, H., Stacchiotti, S., Thomas, D., Maki, R. G., Kroep, J. R., van der Graaf, W. T., Italiano, A., Seddon, B., Dômont, J., et al. (2012) · Cancer · doi:10.1002/cncr.26409 · Cited by 265
Park, M. S., Patel, S. R., Ludwig, J. A., Trent, J. C., Conrad, C. A., Lazar, A. J., Wang, W., Boonsirikamchai, P., Choi, H., Wang, X., et al. (2011) · Cancer · doi:10.1002/cncr.26098 · Cited by 261
Self-citationRadiation-Associated Sarcoma of Bone and Soft Tissue
Brady, M. S. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120013002 · Cited by 258
Lorigan, P., Verweij, J., Papai, Z., Rodenhuis, S., Le Cesne, A., Leahy, M. G., Radford, J. A., Van Glabbeke, M. M., Kirkpatrick, A., Hogendoorn, P. C. W., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7717 · Cited by 256
Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
Gounder, M. M., Lefkowitz, R. A., Keohan, M. L., D'Adamo, D. R., Hameed, M., Antonescu, C. R., Singer, S., Stout, K., Ahn, L., & Maki, R. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3322 · Cited by 255
Bramwell, V, Rouesse, J., Steward, W., Santoro, A., Schraffordt-Koops, H., Buesa, J., Ruka, W., Priario, J., Wagener, T., & Burgers, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1137 · Cited by 244
Schöffski, P., Ray-Coquard, I. L., Cioffi, A., Bui, N. B., Bauer, S., Hartmann, J. T., Krarup-Hansen, A., Grünwald, V., Sciot, R., Dumez, H., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70230-3 · Cited by 244
Penel, N., Le Cesne, A., Bui, B. N., Perol, D., Brain, E. G., Ray-Coquard, I., Guillemet, C., Chevreau, C., Cupissol, D., Chabaud, S., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq341 · Cited by 235
Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma
Kleinerman, R. A., Tucker, M. A., Abramson, D. H., Seddon, J. M., Tarone, R. E., & Fraumeni, J. F. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk002 · Cited by 234
Schlemmer, M., Reichardt, P., Verweij, J., Hartmann, J. T., Judson, I., Thyss, A., Hogendoorn, P. C. W., Marreaud, S., Glabbeke, M. V., & Blay, J. Y. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.037 · Cited by 233
The epidemiology of soft tissue sarcoma.
Zahm, S. H., & Fraumeni, J. F. (1997) · PubMed · Cited by 232
Beverly Raney, R., Walterhouse, D. O., Meza, J. L., Andrassy, R. J., Breneman, J. C., Crist, W. M., Maurer, H. M., Meyer, W. H., Parham, D. M., & Anderson, J. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.4469 · Cited by 230
Nieuwenhuis, M. H., Casparie, M., Mathus‐Vliegen, L. M. H., Dekkers, O. M., Hogendoorn, P. C. W., & Vasen, H. F. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25664 · Cited by 224
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
Grobmyer, S. R., Maki, R. G., Demetri, G. D., Mazumdar, M., Riedel, E., Brennan, M. F., & Singer, S. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh431 · Cited by 224
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)
de Camargo, V. P., Keohan, M. L., D'Adamo, D. R., Antonescu, C. R., Brennan, M. F., Singer, S., Ahn, L. S., & Maki, R. G. (2010) · Cancer · doi:10.1002/cncr.25089 · Cited by 218
Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
Gill, A. J., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181d6150d · Cited by 218
Kawai, A., Araki, N., Sugiura, H., Ueda, T., Yonemoto, T., Takahashi, M., Morioka, H., Hiraga, H., Hiruma, T., Kunisada, T., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70098-7 · Cited by 217
Gaal, J., Stratakis, C. A., Carney, J. A., Ball, E. R., Korpershoek, E., Lodish, M. B., Levy, I., Xekouki, P., van Nederveen, F. H., den Bakker, M. A., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.185 · Cited by 212
Zagars, G. K., Ballo, M. T., Pisters, P. W. T., Pollock, R. E., Patel, S. R., & Benjamin, R. S. (2003) · Cancer · doi:10.1002/cncr.11367 · Cited by 210
Self-citationPappo, A. S., Lyden, E., Breitfeld, P., Donaldson, S. S., Wiener, E., Parham, D., Crews, K. R., Houghton, P., & Meyer, W. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1720 · Cited by 201
Self-citationDocetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis
Bay, J., Ray‐Coquard, I., Fayette, J., Leyvraz, S., Cherix, S., Piperno‐Neumann, S., Chevreau, C., Isambert, N., Brain, E., Emile, G., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21867 · Cited by 189
Sunitinib malate in solitary fibrous tumor (SFT)
Stacchiotti, S., Negri, T., Libertini, M., Palassini, E., Marrari, A., Troia, B. D., Gronchi, A., Tos, A. P. D., Morosi, C., Messina, A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds143 · Cited by 173
Bramwell, V., Anderson, D., Charette, M., & Sarcoma Disease Site Group (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003293 · Cited by 172
Lymph Node Metastasis in Soft Tissue Sarcoma in an Extremity
Riad, S., Griffin, A. M., Liberman, B., Blackstein, M. E., Catton, C. N., Kandel, R. A., O???Sullivan, B., White, L. M., Bell, R. S., Ferguson, P. C., et al. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000141660.05125.46 · Cited by 168
Cormier, J. N., Huang, X., Xing, Y., Thall, P. F., Wang, X., Benjamin, R. S., Pollock, R. E., Antonescu, C. R., Maki, R. G., Brennan, M. F., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.057 · Cited by 163
Self-citationThe role of genetic testing in soft tissue sarcoma
Antonescu, C. R. (2006) · Histopathology · doi:10.1111/j.1365-2559.2005.02285.x · Cited by 160
Mouridsen, H. T., Bastholt, L., Somers, R., Santoro, A., Bramwell, V. H. C., Mulder, J. H., van Oosterom, A. T., Buesa, J., Pinedo, H. M., Thomas, D., et al. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90089-7 · Cited by 154
Nieuwenhuis, M. H., Lefèvre, J. H., Bülow, S., Järvinen, H., Bertario, L., Kernéis, S., Parc, Y. R., & Vasen, H. F. A. (2011) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e318227e4e8 · Cited by 153
Montemurro, M., Schöffski, P., Reichardt, P., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.030 · Cited by 149
Zagars, G. K., Ballo, M. T., Pisters, P. W. T., Pollock, R. E., PATEL, S. R., & Benjamin, R. S. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04510-8 · Cited by 147
Self-citationResponse to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Stacchiotti, S., Tamborini, E., Marrari, A., Brich, S., Rota, S. A., Orsenigo, M., Crippa, F., Morosi, C., Gronchi, A., Pierotti, M. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2050 · Cited by 145
Constantinidou, A., Jones, R. L., Scurr, M. R., Al‐Muderis, O., & Judson, I. R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.08.016 · Cited by 139
Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa
Italiano, A., Delcambre, C., Hostein, I., Cazeau, A. L., Marty, M., Avril, A., Coindre, J., & Bui, B. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq044 · Cited by 139
Ceritinib for ALK-Rearranged Non–Small-Cell Lung Cancer
Tsao, A. S. (2014) · Journal watch · doi:10.1056/nejm-jw.na34146 · Cited by 137
Trent, J. C., Beach, J. L., Burgess, M. A., Papadopolous, N., Chen, L. L., Benjamin, R. S., & PATEL, S. R. (2003) · Cancer · doi:10.1002/cncr.11875 · Cited by 129
Self-citationYoung, R., Natukunda, A., Litière, S., Woll, P. J., Wardelmann, E., & van der Graaf, W. T. A. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.10.004 · Cited by 126
Blay, J., Leahy, M. G., Nguyen, B. B., PATEL, S. R., Hohenberger, P., Santoro, A., Staddon, A. P., Penel, N., Piperno-Neumann, S., Hendifar, A. E., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.012 · Cited by 123
Absi, E. A., Farrokhyar, F., Sharma, R., Whelan, K. F., Corbett, T., Patel, M., & Ghert, M. A. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0885-7 · Cited by 119
Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999
Fallen, T., Wilson, M., Morlan, B. W., & Lindor, N. M. (2006) · Familial Cancer · doi:10.1007/s10689-005-5959-5 · Cited by 118
Park, S. H., Ryu, M., Ryoo, B., Im, S., Kwon, H.-C., Lee, S. S., Park, S. R., Kang, B. Y., & Kang, Y. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9795-9 · Cited by 117
Update on the Biology and Therapy of Gastrointestinal Stromal Tumors
D’Amato, G. Z., Steinert, D. M., McAuliffe, J. C., & Trent, J. C. (2005) · Cancer Control · doi:10.1177/107327480501200106 · Cited by 116
Mascarenhas, L., Lyden, E. R., Breitfeld, P. P., Walterhouse, D. O., Donaldson, S. S., Paidas, C. N., Parham, D. M., Anderson, J. R., Meyer, W. H., & Hawkins, D. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7390 · Cited by 104
Reichardt, P., Tilgner, J., Hohenberger, P., & Dörken, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1438 · Cited by 99
Penel, N., Grosjean, J., Robin, Y. M., Vanseymortier, L., Clisant, S., & Adenis, A. (2008) · Sarcoma · doi:10.1155/2008/459386 · Cited by 96
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
Talbot, S. M., Keohan, M. L., Hesdorffer, M. E., Orrico, R., Bagiella, E., Troxel, A. B., & Taub, R. N. (2003) · Cancer · doi:10.1002/cncr.11730 · Cited by 95
Breitfeld, P. P., Lyden, E. R., Raney, R. B., Teot, L. A., Wharam, M. D., Lobe, T. E., Crist, W., Maurer, H. M., Donaldson, S. S., & Ruymann, F. B. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200105000-00010 · Cited by 90
Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor
Sawaki, A., Nishida, T., Doi, T., Yamada, Y., Komatsu, Y., Kanda, T., Kakeji, Y., Onozawa, Y., Yamasaki, M., & Ohtsu, A. (2011) · Cancer · doi:10.1002/cncr.26120 · Cited by 88
Benson, C., Vitfell-Rasmussen, J., Maruzzo, M., et al. (2014) · PubMed · Cited by 82
Sarcomas in hereditary retinoblastoma
Kleinerman, R. A., Schonfeld, S. J., & Tucker, M. A. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-15 · Cited by 79
Bisgaard, M. L., & Bülow, S. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31010 · Cited by 72
Postow, M. A., & Robson, M. E. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-16 · Cited by 70
High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
Mitchell, G., Ballinger, M. L., Wong, S. Q., Hewitt, C., James, P. A., Young, M., Cipponi, A., Pang, T. W.-Y., Goode, D. L., Dobrovic, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069026 · Cited by 68
Familial Adenomatous Polyposis
Church, J. M. (2009) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2009.07.002 · Cited by 66
Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial
Klingebiel, T., Pertl, U., Hess, C. F., Jürgens, H., Kościelniak, E., Pötter, R., Heek-Romanowski, R. V., Rossi, R., Schött, C., Spaar, H.-J., et al. (1998) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199805)30:5<269::aid-mpo2>3.0.co;2-d · Cited by 66
Vassal, G., Couanet, D., Stockdale, E., Geoffray, A., Geoerger, B., Orbach, D. H., Pichon, F., Gentet, J. C., Picton, S. V., Bergeron, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1960 · Cited by 65
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?
Pfeifer, J. D., Hill, D. A., O’Sullivan, M. J., & Dehner, L. P. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.01107.x · Cited by 61
Self-citationKuttesch, J. F., Krailo, M., Madden, T. L., Johansen, M. J., & Bleyer, A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22133 · Cited by 54
Lymphadenectomy for isolated lymph node metastasis from extremity soft‐tissue sarcomas
Al‐Refaie, W. B., Andtbacka, R. H. I., Ensor, J., Pisters, P. W. T., Ellis, T. L., Shrout, A., Hunt, K. K., Cormier, J. N., Pollock, R. E., & Feig, B. W. (2008) · Cancer · doi:10.1002/cncr.23363 · Cited by 48
Bergeron, C., Thiesse, P., Rey, A., Orbach, D. H., Boutard, P., Thomas, C., Schmitt, C., Scopinaro, M. J., Bernard, F., Stevens, M. C. G., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.007 · Cited by 39
Pappo, A. S., Bowman, L. C., Furman, W. L., Rao, B. N., Kun, L. E., Jenkins, J. J., Crom, W. R., Luo, X., Kaste, S. C., Avery, L., et al. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00006 · Cited by 28
Self-citationRole of chemotherapy in patients with soft tissue sarcomas
Maki, R. G. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.229 · Cited by 24
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma.
Dickson, M. A., Tap, W. D., Keohan, M. L., D’Angelo, S. P., Gounder, M. M., Chi, P., Antonescu, C. R., Landa, J., Qin, L., Rathbone, D. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.10512 · Cited by 2
Self-citation
Cited by
Guidelines for the Management of Soft Tissue Sarcomas
Grimer, R., Judson, I., Peake, D., & Seddon, B. (2010) · Sarcoma · doi:10.1155/2010/506182 · Cited by 432
Improved survival using specialized multidisciplinary board in sarcoma patients
Blay, J.-Y., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx484 · Cited by 371
Dumonceau, J.-M., Deprez, P., Jenssen, C., Iglesias-Garcia, J., Larghi, A., Vanbiervliet, G., Aithal, G., Arcidiacono, P., Bastos, P., Carrara, S., et al. (2017) · Endoscopy · doi:10.1055/s-0043-109021 · Cited by 351
Yu, H. A., Sima, C. S., Huang, J., Solomon, S. B., Rimner, A., Paik, P., Pietanza, M. C., Azzoli, C. G., Rizvi, N. A., Krug, L. M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827e1f83 · Cited by 341
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Blay, J.-Y., Honoré, C., Stoeckle, E., Meeus, P., Jafari, M., Gouin, F., Anract, P., Ferron, G., Rochwerger, A., Ropars, M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz124 · Cited by 338
Metadata
- Authors
- von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Conrad, E. U., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., Kane, J. M., Koon, H., Mayerson, J., McCarter, M., McGarry, S. V., Meyer, C., O'Donnell, R. J., Pappo, A. S., Paz, I. B., Petersen, I. A., Pfeifer, J. D., Riedel, R. F., Schuetze, S., Schupak, K. D., Schwartz, H. S., Tap, W. D., Wayne, J. D., Bergman, M. A., & Scavone, J.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2016-06
- Volume
- 14
- Issue
- 6
- Pages
- 758-786
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4248877280
- Cited by
- 297
- References
- 110
- FWCI
- 37.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.